Literature DB >> 17933491

Oral treatment with ACCUTANE does not increase measures of anhedonia or depression in rats.

Sherry A Ferguson1, F Javier Cisneros, Joseph P Hanig, Kimberly J Berry.   

Abstract

Reports of depression and/or suicide with ACCUTANE (13-cis-retinoic acid (13-cis-RA)) use prompted studies in a rodent model to ascertain its potential effects. Previously, there were no effects on measures of anhedonia (intake of a saccharin-flavored solution) and depression (forced swim test (FST) behaviors) in rats treated with 7.5 or 22.5 mg/kg 13-cis-RA [S.A. Ferguson, F.J. Cisneros, B. Gough, J.P. Hanig, K.J. Berry, Chronic oral treatment with 13-cis-retinoic acid (isotretinoin) or all-trans-retinoic acid does not alter depression-like behaviors in rats, Toxicol. Sci. 87 (2005) 451-459.]. Here, dose and temporal thresholds were investigated by increasing the maximum 13-cis-RA dose to 30 mg/kg, extending treatment duration, and measuring behaviors repeatedly. Beginning on post-natal day 59, male and female Sprague-Dawley rats were gavaged with soybean oil, 7.5 or 30 mg/kg/day of 13-cis-RA for approximately 19 weeks. FST behaviors were measured after 24, 82, and 131 treatment days and saccharin intake (0.03% solution) was measured at baseline and after 14, 35, 56, and 112 treatment days. Body weight and food intake were not altered by treatment. FST durations of swim, climb/struggle, and immobility were unaffected by 13-cis-RA at any time during treatment. More males than females required "rescue" in the FST but there was no treatment effect on number of rats requiring early removal. 13-cis-RA treatment had no effects on saccharin intake at any time. Given that the 7.5 mg/kg dose produces serum levels which parallel those of humans [S.A. Ferguson, P.H. Siitonen, F.J. Cisneros, B. Gough, J.F. Young, Steady state pharmacokinetics of oral treatment with 13-cis-retinoic acid or all-trans-retinoic acid in male and female adult rats, Basic Clin. Pharmacol. Toxicol 98 (2006) 582-587.], these results are quite relevant. Combined with previous results, these results provide further evidence that 13-cis-RA does not produce behavioral alterations indicative of depression in rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17933491     DOI: 10.1016/j.ntt.2007.09.003

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  6 in total

1.  Chronic administration of 13-cis-retinoic acid does not alter the number of serotoninergic neurons in the mouse raphe nuclei.

Authors:  C J G Drew; K C O'Reilly; M A Lane; S J Bailey
Journal:  Neuroscience       Date:  2010-10-25       Impact factor: 3.590

2.  Developmental treatment with ethinyl estradiol, but not bisphenol A, causes alterations in sexually dimorphic behaviors in male and female Sprague Dawley rats.

Authors:  Sherry A Ferguson; Charles Delbert Law; Grace E Kissling
Journal:  Toxicol Sci       Date:  2014-05-05       Impact factor: 4.849

3.  Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study.

Authors:  Anders Sundström; Lars Alfredsson; Gunilla Sjölin-Forsberg; Barbro Gerdén; Ulf Bergman; Jussi Jokinen
Journal:  BMJ       Date:  2010-11-11

4.  High expression of retinoic acid receptors and synthetic enzymes in the human hippocampus.

Authors:  Yara Dadalti Fragoso; Kirsty D Shearer; Angelo Sementilli; Leda Viegas de Carvalho; Peter J McCaffery
Journal:  Brain Struct Funct       Date:  2011-11-11       Impact factor: 3.270

5.  Isotretinoin and psychopathology: a review.

Authors:  Vassilis P Kontaxakis; Demetris Skourides; Panayotis Ferentinos; Beata J Havaki-Kontaxaki; George N Papadimitriou
Journal:  Ann Gen Psychiatry       Date:  2009-01-20       Impact factor: 3.455

6.  All-trans Retinoic Acid-induced Abnormal Hippocampal Expression of Synaptic Genes SynDIG1 and DLG2 is Correlated with Anxiety or Depression-Like Behavior in Mice.

Authors:  Xin-Ya Qin; Hui Fang; Qing-Hong Shan; Cong-Cong Qi; Jiang-Ning Zhou
Journal:  Int J Mol Sci       Date:  2020-04-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.